SF3B1 and myelodysplastic syndrome: The latter finding corroborates previous findings, where higher MCV was observed in SF3B1-mutant MDS when compared with other MDS subtypes46,47, highlighting the role of SF3B1 mutations in erythropoiesis48 and the potential role of PBS RBC morphology in diagnosis.